We are live on ! Find out more
BP

BCK Partners Portfolio holdings

AUM $207M
1-Year Est. Return 18%
This Fund
S&P 500
This Quarter Est. Return
-4.44%
1 Year Est. Return
+18%
3 Year Est. Return
+44.58%
5 Year Est. Return
+37.67%
10 Year Est. Return
AUM
$138M
AUM Growth
-$4.65M
Cap. Flow
+$1.89M
Cap. Flow %
1.37%
Top 10 Hldgs %
92.04%
Holding
28
New
4
Increased
6
Reduced
8
Closed
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
26
Amgen
AMGN
$208B
$249K 0.18%
1,103
AMZN icon
27
Amazon
AMZN
$2.92T
$246K 0.18%
2,180
TMO icon
28
Thermo Fisher Scientific
TMO
$213B
$210K 0.15%
414

Similar funds

BCK Partners's Q3 2022 Portfolio in Review

As of Q3 2022, BCK Partners held 28 positions worth $138M, down 3.3% from $143M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

BCK Partners's Q3 2022 filing shows 4 new, 6 increased and 8 reduced positions. Its largest new stake was State Street SPDR Portfolio Short Term Corporate Bond ETF: 324,710 shares worth $9.49M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $9.28M.

By sector, the portfolio is most concentrated in Healthcare at 1.3% of assets, down from 1.3% a quarter earlier, followed by Technology and Financials.

  • BCK Partners's largest Q3 2022 buy was State Street SPDR Portfolio Short Term Corporate Bond ETF: 324,710 shares worth $9.49M.
  • BCK Partners added most to Vanguard Morningstar Total Stock Market ETF in Q3 2022, an estimated $1.53M increase.
  • BCK Partners's biggest Q3 2022 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $9.28M.
  • BCK Partners's ten largest holdings make up 92% of its $138M portfolio in Q3 2022.
  • BCK Partners opened 4 new positions and closed 0 in Q3 2022.
  • BCK Partners's portfolio value fell 3.3% quarter-over-quarter to $138M.

Based on BCK Partners's 13F filing for Q3 2022, filed 7 Nov 2022.